Real-world utilization pattern of pexidartinib in patients with tenosynovial giant cell tumor (TGCT)

被引：0
|
作者：
Lin, Feng
Tse, Jenny
Shaikh, Nazneen Fatima
Wang, Elizabeth J.
Near, Aimee
Kwong, Jackie
Tap, William D.
机构：
[1] Daiichi Sankyo Inc, Basking Ridge, NJ USA
[2] IQVIA, Durham, NC USA
[3] Mem Sloan Kettering Canc Ctr, Sarcoma Med Oncol Serv, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18792
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Recurrent Tenosynovial Giant Cell Tumor (TGCT) in Thumb Treated by Excision and Adjuvant 3DCRT Radiation
    J. Terrence Jose Jerome
    Loganathan Rajesh Sofia
    Natesan Santhi
    Indian Journal of Orthopaedics, 2022, 56 : 1469 - 1473
  • [42] Recurrent Tenosynovial Giant Cell Tumor (TGCT) in Thumb Treated by Excision and Adjuvant 3DCRT Radiation
    Jerome, J. Terrence Jose
    Sofia, Loganathan Rajesh
    Santhi, Natesan
    INDIAN JOURNAL OF ORTHOPAEDICS, 2022, 56 (08) : 1469 - 1473
  • [43] Tenosynovial Giant Cell Tumor in an Infant
    Shahriari, Shawhin
    Ederle, Ashley
    Botros, James
    Elwood, Hillary
    Shetty, Anil
    JOURNAL OF CRANIOFACIAL SURGERY, 2020, 31 (06) : 1760 - 1762
  • [44] A prospective real-world study of the diffuse-type tenosynovial giant cell tumor patient journey: A 2-year observational analysis
    Bernthal, Nicholas M.
    Healey, John H.
    Palmerini, Emanuela
    Bauer, Sebastian
    Schreuder, Hendrik
    Leithner, Andreas
    Martin-Broto, Javier
    Gouin, Francois
    Lopez-Bastida, Julio
    Gelderblom, Hans
    Staals, Eric L.
    Burke, Zachary D.
    Geiger, Erik J.
    Spierenburg, Geert
    Laeis, Petra
    Beyerlein, Elisabeth
    Ye, Xin
    van de Sande, Michiel
    JOURNAL OF SURGICAL ONCOLOGY, 2022, 126 (08) : 1520 - 1532
  • [45] The diffuse-type tenosynovial giant cell tumor (dt-TGCT) patient journey: a prospective multicenter study
    Bernthal, Nicholas M.
    Spierenburg, Geert
    Healey, John H.
    Palmerini, Emanuela
    Bauer, Sebastian
    Gelderblom, Hans
    Staals, Eric L.
    Lopez-Bastida, Julio
    Fronk, Eva-Maria
    Ye, Xin
    Laeis, Petra
    van de Sande, Michiel A. J.
    ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
  • [46] Multimodal management of tenosynovial giant cell tumors (TGCT) in the landscape of new druggable targets
    van Der Heijden, Lizz
    Spierenburg, Geert
    Kendal, Joseph K. K.
    Bernthal, Nicholas M. M.
    van de Sande, Michiel A. J.
    JOURNAL OF SURGICAL ONCOLOGY, 2023, 128 (03) : 478 - 488
  • [47] Imatinib mesylate for the treatment of locally advanced and/or metastatic pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT).
    Cassier, P. A.
    Stacchiotti, S.
    Gelderblom, H.
    Thomas, D. M.
    Van der Graaf, W.
    Seddon, B. M.
    Julien, D.
    Wagner, A. J.
    Blay, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [48] The diffuse-type tenosynovial giant cell tumor (dt-TGCT) patient journey: a prospective multicenter study
    Nicholas M. Bernthal
    Geert Spierenburg
    John H. Healey
    Emanuela Palmerini
    Sebastian Bauer
    Hans Gelderblom
    Eric L. Staals
    Julio Lopez-Bastida
    Eva-Maria Fronk
    Xin Ye
    Petra Laeis
    Michiel A. J. van de Sande
    Orphanet Journal of Rare Diseases, 16
  • [49] Tenosynovial giant cell tumor: case report of a patient effectively treated with pexidartinib (PLX3397) and review of the literature
    Giustini, Nicholas
    Bernthal, Nicholas M.
    Bukata, Susan V.
    Singh, Arun S.
    CLINICAL SARCOMA RESEARCH, 2018, 8
  • [50] Efficacy and safety of vimseltinib in tenosynovial giant cell tumour (TGCT): Phase II expansion
    Blay, J-Y.
    Gelderblom, H.
    Rutkowski, P.
    Wagner, A.
    van de Sande, M.
    Falcon Gonzalez, A.
    Stacchiotti, S.
    Le Cesne, A.
    Alcindor, T.
    Serrano, C.
    Palmerini, E.
    Ravi, V.
    Casado Herraez, A.
    Seddon, B.
    Vallee, M.
    Jarecha, R.
    Sharma, M.
    Ruiz-Soto, R.
    Sherman, M. L.
    Tap, W. D.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1236 - S1237
12345